Episurf Medical AB (publ) (EPIS-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Episurf Medical AB (publ) (EPIS-B) has a cash flow conversion efficiency ratio of -0.244x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.60 Million ≈ $-1.25 Million USD) by net assets (Skr47.50 Million ≈ $5.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Episurf Medical AB (publ)'s balance sheet to measure how much of total assets are equity-financed.
Episurf Medical AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Episurf Medical AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check EPIS-B capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Episurf Medical AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Episurf Medical AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CONX Corp
NASDAQ:CONX
|
0.026x |
|
Connexion Mobility Ltd
AU:CXZ
|
0.113x |
|
Multi Prima Sejahtera Tbk
JK:LPIN
|
-0.008x |
|
Vivesto AB
ST:VIVE
|
-0.039x |
|
Larq SA
WAR:LRQ
|
0.001x |
|
SAG Holdings Limited
NASDAQ:SAG
|
0.065x |
|
Satria Antaran Prima Tbk PT
JK:SAPX
|
0.018x |
|
Callinex Mines
V:CNX
|
-0.008x |
Annual Cash Flow Conversion Efficiency for Episurf Medical AB (publ) (2010–2025)
The table below shows the annual cash flow conversion efficiency of Episurf Medical AB (publ) from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Episurf Medical AB (publ) stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr47.50 Million ≈ $5.11 Million |
Skr-55.30 Million ≈ $-5.95 Million |
-1.164x | -36.64% |
| 2024-12-31 | Skr83.80 Million ≈ $9.02 Million |
Skr-71.40 Million ≈ $-7.68 Million |
-0.852x | +15.10% |
| 2023-12-31 | Skr84.50 Million ≈ $9.09 Million |
Skr-84.80 Million ≈ $-9.13 Million |
-1.004x | -156.59% |
| 2022-12-31 | Skr177.70 Million ≈ $19.12 Million |
Skr-69.50 Million ≈ $-7.48 Million |
-0.391x | -65.62% |
| 2021-12-31 | Skr252.80 Million ≈ $27.21 Million |
Skr-59.70 Million ≈ $-6.42 Million |
-0.236x | +26.01% |
| 2020-12-31 | Skr169.50 Million ≈ $18.24 Million |
Skr-54.10 Million ≈ $-5.82 Million |
-0.319x | +77.68% |
| 2019-12-31 | Skr41.40 Million ≈ $4.46 Million |
Skr-59.20 Million ≈ $-6.37 Million |
-1.430x | -22.49% |
| 2018-12-31 | Skr44.80 Million ≈ $4.82 Million |
Skr-52.30 Million ≈ $-5.63 Million |
-1.167x | -62.75% |
| 2017-12-31 | Skr85.57 Million ≈ $9.21 Million |
Skr-61.38 Million ≈ $-6.61 Million |
-0.717x | +37.73% |
| 2016-12-31 | Skr48.70 Million ≈ $5.24 Million |
Skr-56.10 Million ≈ $-6.04 Million |
-1.152x | -232.91% |
| 2015-12-31 | Skr109.93 Million ≈ $11.83 Million |
Skr-38.04 Million ≈ $-4.09 Million |
-0.346x | +57.54% |
| 2014-12-31 | Skr38.85 Million ≈ $4.18 Million |
Skr-31.66 Million ≈ $-3.41 Million |
-0.815x | -182.71% |
| 2013-12-31 | Skr71.61 Million ≈ $7.71 Million |
Skr-20.64 Million ≈ $-2.22 Million |
-0.288x | +53.27% |
| 2012-12-31 | Skr24.39 Million ≈ $2.62 Million |
Skr-15.05 Million ≈ $-1.62 Million |
-0.617x | -664.38% |
| 2011-12-31 | Skr48.50 Million ≈ $5.22 Million |
Skr-3.91 Million ≈ $-421.19K |
-0.081x | +60.69% |
| 2010-12-31 | Skr9.74 Million ≈ $1.05 Million |
Skr-2.00 Million ≈ $-215.09K |
-0.205x | -- |
About Episurf Medical AB (publ)
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more